ALISTROL - Lower High Blood Pressure Today!


Aloeride® - Aloe Vera Capsules

Marketing Authorisation - Medicinal Products


Marketing Authorisation: Medicinal Products The case of R (on the application of Merck Sharp and Dohme Ltd) v Licensing Authority [2005], concerned the application for marketing authorisation for a generic product which was based on Product C (see below).

The claimant had marketing authorisations for three medicinal products used in the treatment of osteoporosis and three generic companies sought marketing authorisation for Product C.

Product A - was authorised by the European Community in 1993;

Product B - was authorised in 2000

Product C - was a generic product based on Product B (a copy of Product B).

When a company applies for marketing authorisation for a product, it is a requirement under the European Parliament and Council Directive (EC) 2001/83 (the "Directive"), to supply a full set of data in order to show the safety and efficacy of the product.

There are instances under the Directive when an applicant can simply rely on data submitted in respect of a previously authorised product. For instance, the applicant could refer to data already submitted in respect of a product with marketing authorisation, where the applicant is seeking authorisation for a product 'essentially similar' to a product holding a marketing authorisation for ten years (as per the United Kingdom and pursuant to art 10(i)(a)(iii) of the Directive).

In seeking marketing authorisation for Product C, the generic companies relied on data submitted in relation to Product A and Product B. However, although Product A and Product B contained the same active ingredient, they were not 'essentially similar' within the meaning of the Directive. This meant that they differed in respect of their posology (the schedule of dosage). The defendant accepted that the generic companies did not have to provide any further data but the claimant argued that such an approach was unlawful and in breach of the Directive. The claimant made a reference to the European Court of Justice ("Court of Justice").

The claimant contended that the issue was as yet unresolved by the rules laid down in previous decisions of the ECJ. In particular, it was argued, that there had been no cases where a difference in posology had been the subject of a decision.

The application was dismissed. The ECJ held that:

The principles laid down by the ECJ in earlier decisions were clearly applicable in this case and there was no uncertainty;

Although it was true that a change in posology had not previously been the subject of a decision, it was for the ECJ to interpret the EC Treaty and the relevant principles by which it was to be interpreted, and for the domestic court to apply those principles to the particular case. No new principles arose in the instant case.

If you require further information contact us.

Email: enquiries@rtcoopers.com

© RT COOPERS, 2005. This Briefing Note does not provide a comprehensive or complete statement of the law relating to the issues discussed nor does it constitute legal advice. It is intended only to highlight general issues. Specialist legal advice should always be sought in relation to particular circumstances.

Rosanna Cooper is a partner in RT Coopers Solicitors a full service law firm in London. The firm specialises in patents, trade marks, copyright, designs, technology transfer, biotechnology and pharmaceutical law. The firm has a flexible approach to fees and provides the highest quality legal advice.

Contact us at enquiries@rtcoopers.com. visit our website at http://www.rtcoopers.com

MFIII-Antiaging-Clinic


MiamiHerald.com

Book clubs for doctors show human side of medicine
The Associated Press
Verghese agreed that patient empathy is at the heart of the humanities in medicine movement. He also advocated for a more physician-centric outlook. ...
Book clubs for doctors show human side of medicineNewsday (subscription)
Book clubs for doctors show human side of medicinePennLive.com

all 218 news articles »


Medicine's Future Could Lie in Each Patient's Genome
U.S. News & World Report
"This is another milestone in the inevitable march towards personalized genetic health," said Dr. Robert Marion, chief of genetics and development medicine ...

and more »


Reuters

Individual Genome Sequence Reveals New Charcot-Marie-Tooth Disease Culprits
GenomeWeb Daily News
NEW YORK (GenomeWeb News) – A Baylor College of Medicine-led research team has used whole-genome sequencing of an affected individual to ...
Five new human genomes decoded, marking a transition to more personalized medicineLos Angeles Times (blog)
Sequencing of patients' genomes offers new hope: studiesAFP
The future of medicine has arrivedIndependent
CBC.ca -Popular Science -New York Times
all 182 news articles »


Dangerous medicine
Sify
Chinese inflation: Inflationary days are back in China. Prices rose 2.7 per cent in February, compared to a year earlier, driven by food prices, ...

and more »


TheHorse.com

Speakers to Focus on Translating Regenerative Medicine Science
Newswise (press release)
Newswise — What regenerative medicine therapies are being applied to patients today? What hurdles stand between stem cell therapies and real treatments in ...
STEM CELLSSanta Ynez Valley Journal
Regenerative Medicine Conference Attracts Vets, ResearchersTheHorse.com
Regenerative Medicine & Stem Cell(RMSC)PharmiWeb.com (press release)
MSN Money -San Diego Business Journal -UC Davis
all 54 news articles »


Medco amps up personalized medicine program
FiercePharma
The "personalized medicine" move is designed to target prescriptions to patients who really will benefit from them, saving money and improving healthcare in ...
Personalized Medicine Spurred by Medco's Gene TestingBusinessWeek

all 4 news articles »


Reimer: Acupuncture seems to help where modern medicine failed
Baltimore Sun
Traditional medicine - from podiatrists to orthopedic surgeons - has failed to relieve the pain in my joints caused by years of wear and tear, so I followed ...

and more »


MEDNAX Announces Expansion in Maryland with Acquisition of Maternal-Fetal ...
MarketWatch (press release)
... (NYSE:MD) today announced the acquisition of Maryland Perinatal Associates, PC, a group of four maternal-fetal medicine physicians based in Rockville, ...
Mednax acquires Maryland practiceSouth Florida Business Journal

all 26 news articles »


USC News

Medicine in the dark
Los Angeles Times
Michael Hochman, MD, is an assistant professor of clinical medicine at USC's Keck School of Medicine. Danny McCormick, MD, MPH, is an assistant professor of ...
Most Drug Studies Don't Help Docs Pick Best TreatmentBusinessWeek
Charting a Path From Comparative Effectiveness Funding to Improved Patient ...Journal of American Medical Association (subscription)
Dearth of comparative effectiveness research revealedNature.com (subscription) (blog)
MedPage Today
all 39 news articles »


TopNews United States

Should I Get the Prostate Cancer Test?
New York Times
Dr. Ablin cites two studies, each reported in The New England Journal of Medicine, to support his contention regarding the lack of utility of PSA screening. ...
PSA Discoverer Says PSA Screening is "Public Health Disaster"Medscape
Prostate cancer and menHartford Courant (blog)

all 17 news articles »

Google News

Hibermate home | site map

© 2009 www.elearn-university.org